Sat Sep 28 19:29:37 UTC 2024: ## NEXGEL, Inc. (NXGL) Sees Short Interest Decline, Institutional Investment
**New York, NY** – NEXGEL, Inc. (NASDAQ:NXGL), a company specializing in high water content hydrogels and gels for various applications, saw a notable decrease in short interest during September. As of September 15th, short interest stood at 13,000 shares, representing a 16.7% decline from the previous month. This indicates that fewer investors are betting on a decline in the company’s stock price.
Further contributing to a positive outlook, Northeast Financial Group Inc. acquired a new stake in NEXGEL during the first quarter, valued at approximately $32,000. This institutional investment demonstrates confidence in the company’s future.
While NEXGEL’s stock closed down $0.03 on Friday, trading at $2.59, the company’s overall financial performance appears stable. With a current ratio of 1.36 and a quick ratio of 0.81, NEXGEL has a solid liquidity position. Its debt-to-equity ratio of 0.22 indicates a manageable level of debt.
The company has a market cap of $16.13 million and a price-to-earnings ratio of -4.71, a common feature for companies in the early stages of growth.
NEXGEL, Inc. continues to develop and market its innovative hydrogel technologies for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. With declining short interest and increasing institutional investment, NEXGEL appears poised for continued growth and innovation in the future.
First Piper 